ARNATAR THERAPEUTICS
Live / Allowed — Third extension granted (statement of use) (as of 02 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98549586
- Mark type
- Word mark
- Filed
- 14 May 2024
- Published for opposition
- 24 Dec 2024
- Attorney of record
- Andrew T. Rissler
Goods and services
- Class 005 — Pharmaceuticals: Medicines, namely, medical preparations for preventing or treating cardiovascular and metabolic diseases, as well as rare genetic diseases
Owner
- Arnatar Therapeutics, Inc., San Diego, CA, US
- Arnatar Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 03 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Sept 2026 — SOU EXTENSION 3 GRANTED
- 18 Aug 2026 — SOU EXTENSION 3 FILED
- 01 Sept 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 01 Sept 2026 — NOTICE OF REVIVAL - E-MAILED
- 01 Sept 2026 — PETITION TO REVIVE-GRANTED
- 01 Sept 2026 — TEAS PETITION TO REVIVE RECEIVED
- 28 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2026 — SOU EXTENSION 2 GRANTED
- 17 Feb 2026 — SOU EXTENSION 2 FILED
- 02 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Apr 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION